Partner Courtenay Brinckerhoff was quoted in a BioWorld article, “With BPCIA Dance Optional, Next Moves Up to Biosimilar Sponsors,” on July 24, 2015. The article discussed next steps for biosimilar sponsors after the Federal Circuit confirmed that the Biologic Price Competition and Innovation Act’s intricate patent information exchange is optional. Brinckerhoff said it’s likely that many biosimilar developers will choose not to follow the steps in place by BPCIA since it requires the biosimilar sponsor to give a copy of its application and other confidential manufacturing-related information to the reigning market champion.
People
Related News
June 25, 2025
In the News
Jocelyn Lavallo Explores Nuclear's Emerging Role in Project Finance
Foley & Lardner LLP partner Jocelyn Lavallo examined the increasing relevance of advanced nuclear technologies in the evolving clean energy landscape in her Environment+Energy Leader article, "Nuclear’s Emerging Role in Project Finance: A Cross-Technology Perspective."
June 25, 2025
In the News
Foley Chairman Daljit Doogal Talks Strategic Growth, Expansion into Three New Markets on Podcast
Foley & Lardner LLP Chairman and CEO Daljit Doogal joined an episode of the On the Merits podcast with Bloomberg Law to tell the story of Foley’s successful strategic expansion into three emerging legal markets within the last four years.
June 24, 2025
In the News
Shaalu Mehra Shares His Tech Law Journey – 'I knew I wanted to be in technology'
Foley & Lardner LLP partner Shaalu Mehra joined the HSU untied podcast to discuss his academic background, journey into law, and career path as a technology transactions attorney.